Lombard Odier Asset Management (Switzerland) Sa Pfizer Inc Transaction History

Lombard Odier Asset Management (Switzerland) Sa

$1.14 Billion
Q3 2024

A detailed history of Lombard Odier Asset Management (Switzerland) Sa transactions in Pfizer Inc stock. As of the latest transaction made, Lombard Odier Asset Management (Switzerland) Sa holds 137,425 shares of PFE stock, worth $3.6 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

137,425

Previous 142,329 3.45%

Holding current value

$3.6 Million

Previous $3.98 Million 0.13%

% of portfolio

0.35%

Previous 0.41%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $135,840 - $153,936	-4,904 Reduced 3.45%	137,425 $3.98 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $97,629 - $114,404	3,865 Added 2.79%	142,329 $3.98 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $1.94 Million - $2.23 Million	75,018 Added 118.24%	138,464 $3.84 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $552,283 - $717,355	21,136 Added 49.96%	63,446 $1.83 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $37,994 - $44,411	-1,184 Reduced 2.72%	42,310 $1.4 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $101,280 - $117,179	2,804 Added 6.89%	43,494 $1.6 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $13.6 Million - $17.7 Million	-345,173 Reduced 89.45%	40,690 $1.66 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $1.88 Million - $2.45 Million	-45,035 Reduced 10.45%	385,863 $19.8 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $17.4 Million - $21.2 Million	396,891 Added 1167.09%	430,898 $18.9 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $176,022 - $208,708	-3,783 Reduced 10.01%	34,007 $1.78 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $89,441 - $110,828	1,955 Added 5.46%	37,790 $1.96 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $341,509 - $506,231	-8,265 Reduced 18.74%	35,835 $2.12 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $45,961 - $59,041	1,171 Added 2.73%	44,100 $1.78 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $357,771 - $405,294	9,963 Added 30.22%	42,929 $1.68 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $80,108 - $90,345	2,392 Added 7.82%	32,966 $1.19 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $161,158 - $204,926	4,815 Added 18.69%	30,574 $1.13 Million
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $120,713 - $141,624	3,802 Added 17.32%	25,759 $945,000
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $13.6 Million - $19.5 Million	-504,950 Reduced 95.83%	21,957 $717,000
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $16.3 Million - $18.5 Million	494,668 Added 1534.38%	526,907 $20.6 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $471,592 - $611,516	14,515 Added 81.89%	32,239 $1.16 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $19.4 Million - $21.7 Million	-523,339 Reduced 96.72%	17,724 $768,000
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $1.43 Million - $1.57 Million	-38,110 Reduced 6.58%	541,063 $23 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $48,510 - $55,307	-1,261 Reduced 0.22%	579,173 $25.3 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $7.58 Million - $9.2 Million	220,000 Added 61.04%	580,434 $25.6 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $1.33 Million - $1.42 Million	40,435 Added 12.64%	360,434 $13.1 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $1.72 Million - $1.99 Million	-53,757 Reduced 14.38%	319,999 $11.4 Million
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $1.16 Million - $1.24 Million	-35,000 Reduced 8.56%	373,756 $13.5 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $12.7 Million - $14 Million	408,756	408,756 $14.6 Million

Others Institutions Holding PFE

# of Institutions

3,258

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.

Account

Lombard Odier Asset Management (Switzerland) Sa Pfizer Inc Transaction History